<p>CELEBRATION, Fla., Dec. 27, 2023 (GLOBE NEWSWIRE) — Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) a rare disease therapeutics company, today announced it resubmitted its New Drug Applicatio
European leaders keeping Brexit off the agenda for the time being An update by The Telegraph's Brussels correspondent, James Crisp: Still no discussion on Brexit during the two day summit which h
Leave a Comment